Navigation Links
Covance Increases Early Clinical Footprint in Europe with Acquisition of Swiss-Based Early Clinical Development Site
Date:3/13/2009

and most comprehensive drug development services companies with annual revenues greater than $1.7 billion, global operations in more than 25 countries, and more than 9,600 employees worldwide. Information on Covance's products and services, recent press releases, and SEC filings can be obtained through its website at www.covance.com.

Statements contained in this press release, which are not historical facts, such as statements about prospective earnings, savings, revenue, operations, revenue and earnings growth and other financial results are forward-looking statements pursuant to the safe harbor provisions of the Private Securities Litigation Reform Act of 1995. All such forward-looking statements including the statements contained herein regarding anticipated trends in the Company's business are based largely on management's expectations and are subject to and qualified by risks and uncertainties that could cause actual results to differ materially from those expressed or implied by such statements. These risks and uncertainties include, without limitation, competitive factors, outsourcing trends in the pharmaceutical industry, levels of industry research and development spending, the Company's ability to continue to attract and retain qualified personnel, the fixed price nature of contracts or the loss of large contracts, risks associated with acquisitions and investments, and other factors described in the Company's filings with the Securities and Exchange Commission including its Annual Report on Form 10-K and Quarterly Reports on Form 10-Q. The Company undertakes no duty to update any forward looking statement to conform the statement to actual results or changes in the Company's expectations.


'/>"/>
SOURCE Covance Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2

Related biology technology :

1. Covance Purchases Equity Stake in Caprion Proteomics
2. Covance and Lilly Finalize 10-Year, $1.6 Billion Strategic R&D Collaboration
3. Covance Decides to Pursue Its Original Preclinical Strategy in China
4. Covance and WuXi PharmaTech to Form a Joint Venture to Provide World-Class Preclinical Services in China
5. Covance to Present at The R.W. Baird 2008 Growth Stock Conference
6. Covance to Present at Merrill Lynch Global Pharmaceutical, Biotechnology and Medical Device Conference
7. Covance Reports Full-Year 2007 Revenue Growth Of 15.4% and Seventh Consecutive Year of EPS Growth in Excess of 20%
8. Covance Inc. Invites You to Join the Webcast of Its Third Quarter 2007 Financial Results Conference Call
9. Simbionix Increases Product Offerings for OB/GYN Physicians
10. R&D Spending by U.S. Biopharmaceutical Companies Increases 3 Percent in 2008
11. Despite Economic Woes, Physician Compensation Increases
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/24/2014)... group leader Yung-Eun Sung has announced that they ... nitrogen-doped graphenes which can be applied as high ... Yung-Eun Sung is both a group leader at ... Basic Science* (IBS) and a professor at the ... significance with regards to the development of relative ...
(Date:7/24/2014)... -- Research and Markets has announced the ... report to their offering.  ... in vitro growth of plant or animal cells for ... production. Cell culture is a crucial step in tissue ... culture consumables are necessary for the in vitro production ...
(Date:7/24/2014)... July 24, 2014  CorMedix Inc. (NYSE MKT: ... commercializing therapeutic products for the prevention and treatment ... of notice on July 18, 2014 from the ... accepted the CorMedix plan to regain compliance with ... result, the NYSE-MKT is continuing the Company,s listing ...
(Date:7/24/2014)... N.J. , July 24, 2014 ... provider of regulatory and ethical review services for ... Alliance Biosciences. Formerly a division of ... was the leading biosafety and biosecurity consulting firm ... With this addition, WCG,s biosafety division – WCG ...
Breaking Biology Technology:Global Cell Culture Market 2014-2018: Key Vendors are Becton, Dickinson and Co, EMD, GE Healthcare, Lonza Group, Sigma Aldrich and Thermo Fisher Scientific 2CorMedix, Inc. Granted Extension of NYSE-MKT Listing 2CorMedix, Inc. Granted Extension of NYSE-MKT Listing 3WIRB-Copernicus Group Announces Acquisition of Alliance Biosciences; Executives Join WCG Biosafety Division 2WIRB-Copernicus Group Announces Acquisition of Alliance Biosciences; Executives Join WCG Biosafety Division 3
... May 21 Martek Biosciences,Corporation (Nasdaq: MATK ) ... UBS Global Generic and Specialty Pharmaceuticals Conference in,London. The ... at the Waldorf,Hilton, Aldwych, London. Steve Dubin, CEO will ... EDT (2:00 p.m. London Time)., Interested parties may ...
... Still River Systems announces,the successful development and operation ... of the development of its Monarch250(TM) proton,therapy system. ... conclusively,demonstrates that cyclotrons at this high field strength ... By increasing the operating,magnetic field, Still River Systems ...
... N.J., May 21 Aton Pharma, Inc., a ... signed a,marketing and distribution agreement with PharmaLink Asia ... into several countries in Asia and,Australia., "This ... we execute,our mission to expand access to our ...
Cached Biology Technology:Still River Systems Announces Operation of the World's Highest Magnetic Field Cyclotron 2Aton Pharma Announces Distribution Partnership in the Asia Pacific Region 2
(Date:7/23/2014)... , July 24, 2014 Pfenex Inc. (NYSE ... offering of 8,333,333 shares of its common stock at a ... Pfenex has granted the underwriters a 30-day option to purchase ... initial public offering price. The shares are expected to begin ... the symbol "PFNX". William Blair & ...
(Date:7/23/2014)... or neglected early in life are at risk ... In a new study, scientists have found that ... has implications for children,s long-term development. Previous studies ... and genetics interacted with that child,s experiences in ... In the new study, researchers were able to ...
(Date:7/23/2014)... crow and the pitcher, a thirsty bird happens upon a ... it, he finds the water level out of his reach. ... drops pebbles into it one at a time ... his fill. , Highlighting the value of ingenuity, the fable ... brute force. It also characterizes crows as pretty resourceful problem ...
Breaking Biology News(10 mins):Pfenex Inc. Announces Pricing Of Initial Public Offering 2Stress tied to change in children's gene expression related to emotion regulation, physical health 2Stress tied to change in children's gene expression related to emotion regulation, physical health 3Smarter than a first-grader? 2Smarter than a first-grader? 3Smarter than a first-grader? 4
... Researchers have identified a gene that appears to increase a ... type of Alzheimer,s disease. The research will be presented as ... of Neurology,s 62nd Annual Meeting in Toronto, April 10 ... six. "Only recently have common variants in genes ...
... who co-piloted the historic 1960 deep-sea voyage of the Trieste, will ... on at 10 a.m. April 15 at the U.S. Navy Museum ... to have visited the Challenger Deep the deepest part of ... navigating the bathyscaphe (deep submergence vehicle) Trieste 35,810 feet down to ...
... 13, 2010 -- Two chemists at The Scripps Research Institute have ... that turns itself on or off as it detects metallic ions ... the April 19, 2010 issue of the International Edition of the ... tool for controlling tiny reactions in the test tube, and it ...
Cached Biology News:New gene associated with increased risk of Alzheimer's disease 2New nano-tool synthesized at Scripps Research Institute 2
... Visualizer DX's sensitivity of DNA detection has been ... in an agarose gel can be detected > ... can be purified by organic solvent extraction or ... kits worked well.) DNA excised from agarose ...
Mouse monoclonal antibody raised against a full length recombinant CSNK2A2. NCBI Entrez Gene ID = CSNK2A2...
... Small space saving design - ideal for personal ... models: , - 3D gyratory action SSM3 , ... speed control and built-in timer , Optional tier system ... ideal where gentle mixing is required, either on the ...
... The TargeTron(TM) Gene Knockout System provides optimized ... specific disruption of bacterial genes by insertion ... the retrohoming ability of group II introns ... re-target the TargeTron group II intron for ...
Biology Products: